http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109651532-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-736 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-009 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-736 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate | 2018-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-109651532-B |
titleOfInvention | Dendrobium officinale glucomannan |
abstract | The invention discloses dendrobium officinale glucomannan, which is characterized in that the weight average relative average molecular weight of the dendrobium officinale glucomannan is 398.4 kDa; the molar ratio of mannose to glucose in the dendrobium officinale glucomannan is 5.32:1, the sugar chain connection mode is 1,4-Man (p): 1,4-glc (p): t-Man (p): t-glc (p) molar ratio 3.77: 1.00: 0.08: 0.03. the extraction method comprises the following steps: extraction of crude dendrobium officinale polysaccharide, separation of dendrobium officinale refined polysaccharide and purification of purified dendrobium officinale polysaccharide. The novel dendrobium officinale glucomannan provided by the invention has good activity for resisting melanoma cells, and has good application prospect in preparation of anti-tumor drugs. |
priorityDate | 2018-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 48.